Novel Therapy Strategy for Early CKD Progression: Slowing Down and Preventing ESKD
The high frequency, persistent nature, substantial financial impact, and restricted therapeutic alternatives of renal illnesses pose a significant risk to human well-being. Therefore, it is imperative to implement a novel treatment approach that can delay the advancement of CKD during its initial phases and forestall the onset of ESKD to alleviate the suffering of patients.
原文地址: https://www.cveoy.top/t/topic/l4LU 著作权归作者所有。请勿转载和采集!